
Tulisokibart was designed to help address immuno-fibrosis, a key driver of disease progression in HS

The mRNA-based therapy, used with Keytruda, is designed specifically for each patient

Weinreich will be based in Billerica, Massachusetts at the company’s Research and Development site

More than 9,700 new cases of endometrial cancer are diagnosed every year in the UK

A new restructuring programme has been approved to support the initiative

Illnesses caused by Streptococcus pneumoniae are currently considered a major public health problem by WHO

Cardiovascular diseases result in an estimated 17.9 million global deaths each year

Approximately one in every 70,000 people are affected by the tumour-causing genetic disease

The partners will evaluate MK-6070 as part of a combination treatment for small cell lung cancer

More than 165,000 new cases of bladder cancer are diagnosed in the EU every year

More than 6,500 new cases of gastric cancer are diagnosed in the UK every year

The respiratory virus accounts for about 30,000 hospitalisations in children under five every year in the UK